MyFinsight
Home
Blog
About
Marketable securities
$450,285K
(-11.31%↓ Y/Y)
Cash and cash
equivalents
$48,876K
(-0.50%↓ Y/Y)
Prepaid expenses and
other assets, current
$28,332K
(95.03%↑ Y/Y)
Total current assets
$527,493K
(-7.68%↓ Y/Y)
Other assets,
noncurrent
$5,491K
Total assets
$532,984K
(-7.87%↓ Y/Y)
Total liabilities and
stockholders' equity
$532,984K
(-7.87%↓ Y/Y)
Total stockholders'
equity
$407,758K
(-12.92%↓ Y/Y)
Total liabilities
$125,226K
(13.58%↑ Y/Y)
Accumulated deficit
-$991,370K
(-68.18%↓ Y/Y)
Accumulated other
comprehensive (loss) income
-$403K
(-176.47%↓ Y/Y)
Additionalpaid-incapital
$1,399,459K
(32.38%↑ Y/Y)
Long-term debt
$75,228K
(1.03%↑ Y/Y)
Total current
liabilities
$48,321K
(44.01%↑ Y/Y)
Other liabilities,
noncurrent
$1,677K
Class a common stock,
0.001 par value...
$72K
(12.50%↑ Y/Y)
Accrued expenses and
other liabilities,...
$33,748K
(72.69%↑ Y/Y)
Accounts payable
$14,573K
(10.76%↑ Y/Y)
Back
Back
Balance Sheet
Vera Therapeutics, Inc. (VERA)
Vera Therapeutics, Inc. (VERA)
source: myfinsight.com